In a groundbreaking study published in the Journal of the American Chemical Society (JACS), researchers have decoded the intricate defense mechanism employed by bacteria to protect themselves from predators. Led by Pierre Stallforth, Ute Hellmich, and Markus Lakemeyer, the team has unveiled how bacteria of the genera Pseudomonas and Paenibacillus collaborate to fend off amoebas. This research, conducted by the Cluster of Excellence Balance of the Microverse at the University of Jena, marks a significant advancement in understanding microbial interactions.
The announcement comes as a continuation of work initiated in 2021 by Stallforth and his team at the Leibniz-Institute for Natural Product Research and Infection Biology (Leibniz-HKI). They had previously observed the symbiotic relationship between these bacteria, but the precise molecular workings were yet to be uncovered—until now.
Unraveling the Molecular Defense
The cooperation between Pseudomonas sp. SZ40 and Paenibacillus sp. SZ31 hinges on a natural product known as syringafactin, a lipopeptide produced by Pseudomonas. This compound becomes lethal to the amoeba only after undergoing a transformation facilitated by Paenibacillus. The latter employs two specialized enzymes, DL peptidases, to cleave the lipopeptide at an unusual site, rendering it toxic to the predator.
“It was very exciting for me to understand the mechanism by which the special class of DL lipopeptides is cleaved and how this can be exploited in the interaction of microbes,” reports Hellmich. The unique aspect of these natural products lies in their unusual site of attack within the lipopeptide’s spatial structure.
Understanding the Enzymatic Process
Stallforth explains, “Amino acids are normally L-configured in nature, which is why most enzymes are specialized in cleaving this variant.” The D and L forms, though mirror images with identical atomic compositions, present a significant challenge for analysis. “For many analytical methods, both molecules look the same, even though we know that there is a huge difference between using the left or right hand,” Hellmich illustrates.
Implications for Natural Product Research
According to Stallforth, this alteration is not an isolated phenomenon but appears to be a general, albeit specific, mechanism. “These enzymes are so interesting because we can use them to elucidate the structure of complex natural substances by selectively dividing them into smaller fragments,” he notes. This discovery holds promise for the development of new natural product-based anti-infectives.
Lakemeyer adds, “And that will make it easier for us and other groups to analyze new natural substances in the future.” This advancement is poised to significantly aid the development of novel therapeutic agents.
Collaboration: The Key to Success
Much like the bacteria they study, the research team thrived on collaboration. Hellmich emphasizes the importance of interdisciplinary cooperation: “Individually, none of us would have been able to tackle this problem in this way.” The synergy in Jena allowed the team to explore the problem from multiple angles, from small natural substances to protein structures in cells, and even the ecological context.
“I have never experienced anything like Jena at any other location,” Lakemeyer remarks. “It’s just fun when you can look at the same problem from different angles and then also have great colleagues.”
Broader Impacts and Future Directions
This study, a collaboration between Leibniz-HKI and the Universities of Jena and Würzburg, was supported by the Werner Siemens Foundation, the Balance of the Microverse Cluster of Excellence, and the ChemBioSys Collaborative Research Center. The research networks involved played a crucial role in facilitating this breakthrough.
The exciting dynamics of in-person collaboration were particularly evident in Jena. “You can sit down together in a café on a Sunday and say, ‘We need to analyze the data now,'” says Lakemeyer, highlighting the collegial spirit among researchers.
The team involved in this pioneering work includes Shuaibing Zhang, Ying Huang, Kevin Schlabach, Mai Anh Tran, Raed Nachawati, Anna Komor, Christian Hertweck, and Pierre Stallforth from Leibniz-HKI, Markus Lakemeyer and Ute Hellmich from Friedrich Schiller University Jena, and Nicole Bader and Hermann Schindelin from Julius Maximilian University of Würzburg.
As the scientific community digests these findings, the implications for future research are vast. The elucidation of this bacterial defense mechanism not only advances our understanding of microbial interactions but also opens new avenues for the development of innovative anti-infective therapies.
